Proliferation of type II pneumocytes in the lung biopsy specimens reflecting alveolar damage☆

Received 28 December 2001; accepted 4 June 2002.

Abstract

Proliferation of type II pneumocytes may be the most sensitive pathological indicator of alveolitis, and the density of type II pneumocytes reflecting the severity of the recent alveolar damage. Twenty-nine patients were divided into three groups by the severity of ground-glass opacities on the CT scans; the severe (acute), the moderate (subacute) and the mild (chronic) groups. We compared the density of type II pneumocytes in the transbronchial lung biopsy specimens and cell analysis of bronchoalveolar lavage (BAL) fluid with the ground-glass opacities. Clinical and laboratory findings and BAL fluid analysis also corresponded well with this grouping. Type II pneumocytes were selectively stained with an antibody against Thomsen–Friedenreich and the density of the type II pneumocytes was expressed as the number per 1 mm alveolar septal length. The densities of the type II pneumocytes in the severe, the moderate, the mild, and the control groups were 21.2±1.1, 14.4±7.2, 11.0±3.3 and 7.5±0.9/mm, respectively. There were significant differences between the acute group and the other three groups, and between the control and chronic groups. The density of type II pneumocytes is a useful index for evaluating alveolar damage even in mild alveolitis.

Keywords: interstitial pneumonia, pneumocytes, alveolitis, lung biopsy, bronchoscopy.

No full text is available. To read the body of this article, please view the PDF online.

Article Outline

• Abstract

• References

• Copyright

References

REFERENCES

1. 1 Hallgren R, Bjermer L, Lundgren R, Venge P. The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function. Am Rev Respir Dis. 1989;139:373–377. MEDLINE

2. 2 Kohno N, Awaya Y, Oyama T. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis. 1993;148:637–642. MEDLINE

3. 3 Matusiewicz SP, Williamson IJ, Sime PJ. Plasma lactate dehydrogenase: a marker of disease activity in cryptogenic fibrosing alveolitis and extrinsic allergic alveolitis?. Eur Respir J. 1993;6:1282–1286. MEDLINE

4. 4 Muller NL, Staples CA, Miller RR, Vedal S, Thurlbeck WM, Ostrow DN. Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation. Radiology. 1987;165:731–734. MEDLINE

5. 5 Miller RR, Evans KG. Lung biopsy. In: Thurlbeck WM, Churg AM editor. Pathology of the Lung. New York: Thieme Medical Publishers; 1995;.

6. 6 Cherniack RM, Colby TV, Flint A. Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. The BAL Cooperative Group Steering Committee. Am Rev Respir Dis. 1991;144:892–900. MEDLINE

7. 7 Evans MJ, Dekker NP, Cabral-Anderson LJ, Freeman G. Quantitation of damage to the alveolar epithelium by means of type 2 cell proliferation. Am Rev Respir Dis. 1978;118:787–790. MEDLINE

8. 8 Kaplan HP, Robinson FR, Kapanci Y, Weibel ER. Pathogenesis and reversibility of the pulmonary lesions of oxygen toxicity in monkeys. I. Clinical and light microscopic studies. Lab Invest. 1969;20:94–100. MEDLINE

9. 9 Katzenstein A-L A. Katzenstein and Askin's Surgical Pathology of Non-neoplastic Lung Disease. Philadelphia: W.B. Saunders Company; 1997;.

10. 10 Kuhn C. Patterns of lung repair. a morphologist's view. Chest. 1991;99:11S–14S. MEDLINE | CrossRef

11. 11 McDonald JA. Idiopathic pulmonary fibrosis. A paradigm for lung injury and repair. Chest. 1991;99:87S–93S. MEDLINE | CrossRef

12. 12 Colby TV, Carrington CB. Interstitial lung disease. In: Thurlbeck WM, Churg AM editor. Pathology of the Lung. New York: Thieme Medical Publishers; 1995;.

13. 13 Honda T, Hayasaka M, Hachiya T, Ota H, Katsuyama T. Carbohydrate histochemistry of the apical membranes of Non-ciliated bronchiolar cells and type II pneumocytes in six mammalian species. Acta Histochem Cytochem. 1995;28:107–117.

14. 14 Hayasaka M, Honda T, Kubo K, Sekiguchi M. Proliferation of type II pneumocytes and alteration in their apical surface membrane antigenicity in pulmonary sarcoidosis. Chest. 1999;116:477–483. MEDLINE | CrossRef

15. 15 Honda T, Ishida K, Hayama M, Kubo K, Katsuyama T. Type II pneumocytes are preferentially located along thick elastic fibers forming the framework of human alveoli. Anat Rec. 2000;258:34–38.

16. 16 Fawcett DW. A Textbook of Histology. London: Chapman & Hall; 1994;.

17. 17 Weiss L, Greep RO. Histology. New York: McGraw-Hill Book Company; 1977;.

18. 18 Muller NL, Miller RR, Webb WR, Evans KG, Ostrow DN. Fibrosing alveolitis: CT-pathologic correlation. Radiology. 1986;160:585–588. MEDLINE

19. 19 Remy JM, Remy J, Giraud F, Wattinne L, Gosselin B. Computed tomography assessment of ground-glass opacity: semiology and significance. J Thorac Imaging. 1993;8:249–264. MEDLINE | CrossRef

20. 20 Mornex JF, Cordier G, Pages J. Activated lung lymphocytes in hypersensitivity pneumonitis. J Allergy Clin Immunol. 1984;74:719–727. MEDLINE | CrossRef

a Department of Laboratory Medicine, Shinshu University School of Medicine, Matsumoto, Japan

b Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan

c Department of Radiology, Shinshu University School of Medicine, Matsumoto, Japan

☆ Correspondence should be addressed to: Dr Takayuki Honda, MD, PhD, Department of Laboratory Medicine, Shinshu University School of Medicine, Asahi 3-1-1, Matsumoto, 390-8621, Japan. Fax: +80 263 34 5316; E-mail: thondat@hsp.md.shinshu-u.ac.jp

† Present address: Department of Medical Technology, School of Allied Medical Sciences, Shinshu University, Asahi 3-1-1,Matsumoto 390-8621, Japan.

¶ Present address: Azumi General Hospital, Ikeda, Nagano, 399-8695, Japan.

PII: S0954-6111(02)91408-3

doi:10.1053/rmed.2002.1408

14 of 18